Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 2.04
NAS:STAA's Cash to Debt is ranked higher than
55% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. NAS:STAA: 2.04 )
Ranked among companies with meaningful Cash to Debt only.
NAS:STAA' s Cash to Debt Range Over the Past 10 Years
Min: 0.08  Med: 2.02 Max: 9.66
Current: 2.04
0.08
9.66
Equity to Asset 0.57
NAS:STAA's Equity to Asset is ranked lower than
53% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. NAS:STAA: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
NAS:STAA' s Equity to Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.65 Max: 0.81
Current: 0.57
0.29
0.81
F-Score: 3
Z-Score: 6.65
M-Score: -3.30
WACC vs ROIC
13.65%
-45.21%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -17.22
NAS:STAA's Operating margin (%) is ranked lower than
73% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. NAS:STAA: -17.22 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:STAA' s Operating margin (%) Range Over the Past 10 Years
Min: -27.22  Med: -5.94 Max: 4.43
Current: -17.22
-27.22
4.43
Net-margin (%) -15.78
NAS:STAA's Net-margin (%) is ranked lower than
71% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. NAS:STAA: -15.78 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:STAA' s Net-margin (%) Range Over the Past 10 Years
Min: -30.97  Med: -8.35 Max: 2.15
Current: -15.78
-30.97
2.15
ROE (%) -33.27
NAS:STAA's ROE (%) is ranked lower than
76% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. NAS:STAA: -33.27 )
Ranked among companies with meaningful ROE (%) only.
NAS:STAA' s ROE (%) Range Over the Past 10 Years
Min: -88.78  Med: -19.65 Max: 5.2
Current: -33.27
-88.78
5.2
ROA (%) -20.11
NAS:STAA's ROA (%) is ranked lower than
74% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. NAS:STAA: -20.11 )
Ranked among companies with meaningful ROA (%) only.
NAS:STAA' s ROA (%) Range Over the Past 10 Years
Min: -43.45  Med: -10.93 Max: 3.01
Current: -20.11
-43.45
3.01
ROC (Joel Greenblatt) (%) -42.10
NAS:STAA's ROC (Joel Greenblatt) (%) is ranked lower than
72% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. NAS:STAA: -42.10 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:STAA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -131.74  Med: -18.54 Max: 22.07
Current: -42.1
-131.74
22.07
Revenue Growth (3Y)(%) 3.70
NAS:STAA's Revenue Growth (3Y)(%) is ranked lower than
51% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. NAS:STAA: 3.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:STAA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -12.5  Med: -6.7 Max: 9.6
Current: 3.7
-12.5
9.6
EPS Growth (3Y)(%) 50.40
NAS:STAA's EPS Growth (3Y)(%) is ranked higher than
88% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. NAS:STAA: 50.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:STAA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -40.5  Med: -22.3 Max: 50.4
Current: 50.4
-40.5
50.4
» NAS:STAA's 10-Y Financials

Financials (Next Earnings Date: 2017-03-02)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

STAA Guru Trades in Q4 2015

Jim Simons 14,200 sh (New)
» More
Q1 2016

STAA Guru Trades in Q1 2016

Jim Simons 150,400 sh (+959.15%)
» More
Q2 2016

STAA Guru Trades in Q2 2016

Jim Simons 162,700 sh (+8.18%)
» More
Q3 2016

STAA Guru Trades in Q3 2016

Jim Simons 128,200 sh (-21.20%)
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:LMAT, AMEX:CRHM, NAS:MLAB, NAS:CFMS, NAS:OSUR, OTCPK:GMDTF, NAS:ENTL, NAS:ATRS, NAS:ANGO, NAS:UTMD, NAS:ELGX, NAS:ATRC, AMEX:TRXC, NAS:SIEN, NAS:DSCI, OTCPK:NNCSF, NAS:BIOL, NAS:NVCR, AMEX:BVX, NAS:IVTY » details
Traded in other countries:SR3.Germany,
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses.

Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses. The Company was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The lenses are used in corrective or refractive surgery. The Company also makes lenses for use in surgery that treats cataracts. The Company operates as one operating segment, the ophthalmic surgical market. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company competes with other elective surgical procedures such as laser vision correction or LASIK, for those consumers who are looking for an alternative to eyeglasses or contact lenses to correct their vision.

Ratios

vs
industry
vs
history
Forward P/E 217.39
STAA's Forward P/E is ranked lower than
100% of the 36 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.22 vs. STAA: 217.39 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 11.30
STAA's P/B is ranked lower than
94% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.12 vs. STAA: 11.30 )
Ranked among companies with meaningful P/B only.
STAA' s P/B Range Over the Past 10 Years
Min: 1.37  Med: 7.27 Max: 17.59
Current: 11.3
1.37
17.59
P/S 5.17
STAA's P/S is ranked lower than
72% of the 222 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.98 vs. STAA: 5.17 )
Ranked among companies with meaningful P/S only.
STAA' s P/S Range Over the Past 10 Years
Min: 0.31  Med: 3.43 Max: 9.89
Current: 5.17
0.31
9.89
EV-to-EBIT -30.96
STAA's EV-to-EBIT is ranked lower than
99.99% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.14 vs. STAA: -30.96 )
Ranked among companies with meaningful EV-to-EBIT only.
STAA' s EV-to-EBIT Range Over the Past 10 Years
Min: -1066  Med: -13 Max: 4076.4
Current: -30.96
-1066
4076.4
EV-to-EBITDA -38.99
STAA's EV-to-EBITDA is ranked lower than
99.99% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. STAA: -38.99 )
Ranked among companies with meaningful EV-to-EBITDA only.
STAA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -915.4  Med: -5.9 Max: 16916.2
Current: -38.99
-915.4
16916.2
Current Ratio 2.34
STAA's Current Ratio is ranked lower than
53% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. STAA: 2.34 )
Ranked among companies with meaningful Current Ratio only.
STAA' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 2.53 Max: 3.77
Current: 2.34
1.06
3.77
Quick Ratio 1.59
STAA's Quick Ratio is ranked lower than
51% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. STAA: 1.59 )
Ranked among companies with meaningful Quick Ratio only.
STAA' s Quick Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.51 Max: 2.37
Current: 1.59
0.55
2.37
Days Inventory 237.72
STAA's Days Inventory is ranked lower than
86% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.20 vs. STAA: 237.72 )
Ranked among companies with meaningful Days Inventory only.
STAA' s Days Inventory Range Over the Past 10 Years
Min: 154.29  Med: 194.54 Max: 236.64
Current: 237.72
154.29
236.64
Days Sales Outstanding 64.64
STAA's Days Sales Outstanding is ranked lower than
55% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. STAA: 64.64 )
Ranked among companies with meaningful Days Sales Outstanding only.
STAA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.05  Med: 50.88 Max: 74.19
Current: 64.64
41.05
74.19
Days Payable 121.27
STAA's Days Payable is ranked higher than
82% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.76 vs. STAA: 121.27 )
Ranked among companies with meaningful Days Payable only.
STAA' s Days Payable Range Over the Past 10 Years
Min: 58.49  Med: 78.59 Max: 104.35
Current: 121.27
58.49
104.35

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 1.20
STAA's Yield on cost (5-Year) is ranked lower than
68% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.89 vs. STAA: 1.20 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STAA' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 1.2
3-Year Average Share Buyback Ratio -3.10
STAA's 3-Year Average Share Buyback Ratio is ranked higher than
50% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. STAA: -3.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STAA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.1  Med: -6 Max: -1.6
Current: -3.1
-13.1
-1.6

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 20.20
STAA's Price/Net Current Asset Value is ranked lower than
81% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.55 vs. STAA: 20.20 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
STAA' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.23  Med: 12.16 Max: 45.33
Current: 20.2
2.23
45.33
Price/Tangible Book 12.07
STAA's Price/Tangible Book is ranked lower than
91% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.38 vs. STAA: 12.07 )
Ranked among companies with meaningful Price/Tangible Book only.
STAA' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.94  Med: 7.12 Max: 24.29
Current: 12.07
0.94
24.29
Price/Projected FCF 42.00
STAA's Price/Projected FCF is ranked lower than
97% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. STAA: 42.00 )
Ranked among companies with meaningful Price/Projected FCF only.
STAA' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.87  Med: 17.39 Max: 147.8
Current: 42
0.87
147.8
Price/Median PS Value 1.51
STAA's Price/Median PS Value is ranked lower than
76% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.08 vs. STAA: 1.51 )
Ranked among companies with meaningful Price/Median PS Value only.
STAA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.11  Med: 0.92 Max: 2.84
Current: 1.51
0.11
2.84
Earnings Yield (Greenblatt) (%) -3.20
STAA's Earnings Yield (Greenblatt) (%) is ranked lower than
66% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. STAA: -3.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STAA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.2  Med: 0.5 Max: 0.9
Current: -3.2
0.2
0.9

More Statistics

Revenue (TTM) (Mil) $81.15
EPS (TTM) $ -0.32
Beta1.52
Short Percentage of Float9.50%
52-Week Range $4.98 - 11.15
Shares Outstanding (Mil)40.61

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 82 89 98
EPS ($) -0.19 0.05 0.20
EPS w/o NRI ($) -0.19 0.05 0.20
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:STAA

Headlines

Articles On GuruFocus.com
Insider Trades of the Week: Facebook, Delta Air Lines May 20 2016 
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 

More From Other Websites
ETFs with exposure to STAAR Surgical Co. : November 23, 2016 Nov 23 2016
STAAR Surgical Co. :STAA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016 Nov 22 2016
STAAR SURGICAL CO Financials Nov 10 2016
STAAR Surgical Co. breached its 50 day moving average in a Bullish Manner : STAA-US : November 9,... Nov 09 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 07 2016
Staar Surgical reports 3Q loss Nov 03 2016
Staar Surgical reports 3Q loss Nov 03 2016
STAAR Surgical Co Earnings Call scheduled for 4:30 pm ET today Nov 03 2016
STAAR Surgical Reports Third Quarter 2016 Results Nov 03 2016
STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition Nov 03 2016
STAAR Surgical Reports Third Quarter 2016 Results Nov 03 2016
Q3 2016 STAAR Surgical Co Earnings Release - After Market Close Nov 03 2016
STAAR Surgical Co. breached its 50 day moving average in a Bearish Manner : STAA-US : October 26,... Oct 26 2016
STAAR Surgical to Report Third Quarter Results on November 3, 2016 Oct 20 2016
STAAR Surgical to Report Third Quarter Results on November 3, 2016 Oct 20 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure Sep 22 2016
STAAR Surgical Announces Approval by Health Canada of Its EVO Visian ICL™ Toric Lens Specifically... Sep 22 2016
STAAR Surgical Announces Approval by Health Canada of Its EVO Visian ICL™ Toric Lens Specifically... Sep 22 2016
STAAR Surgical Announces Strategic Cooperation Agreement With World Eye Hospital Group Sep 17 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure Sep 15 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)